Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
P2X4 receptors control the fate and survival of activated microglia.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
Predictors of successful acceptance of home telemanagement in veterans with Multiple Sclerosis.
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.
Acute recovery from exercise in people with multiple sclerosis: an exploratory study on the effect of exercise intensities.
The road to remyelination in demyelinating diseases: current status and prospects for clinical treatment.
The influence of immunomodulatory treatment on the clinical course of multiple sclerosis.
Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG.
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.
Pycnogenol Attenuates the Release of Proinflammatory Cytokines and Expression of Perilipin 2 in Lipopolysaccharide-Stimulated Microglia in Part via Inhibition of NF-κB and AP-1 Activation.
The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.
Ultra-small superparamagnetic iron oxide enhancement is associated with higher loss of brain tissue structure in clinically isolated syndrome.
Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography.
IL-21R signaling is critical for induction of spontaneous experimental autoimmune encephalomyelitis.
Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a.
Structural and construct validity of the Leeds Multiple Sclerosis Quality of Life scale.
Mesenchymal stem cells of dental origin - their potential for anti-inflammatory and regenerative actions in brain and gut damage.
Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.
Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis.
Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients.
Warmer outdoor temperature is associated with task-related increased BOLD activation in patients with multiple sclerosis.
A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.
Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature.
Bevacizumab is safe in acute relapses of neuromyelitis optica.
Pages
« first
‹ previous
…
640
641
642
643
644
645
646
647
648
…
next ›
last »